Search Results 121-130 of 409 for ‼보증사이트 [원탑보증.com/가입코드 111] 어코드 ‼

1. Publications - Peter A. Noseworthy, M.D., M.B.A. - Mayo Clinic

   2024 Apr; 5 (2):111-114 Epub 2024 Feb 24. View PubMed; Christopoulos G, Attia ZI, Achenbach SJ, Rabe KG, Call TG, Ding W, Leis JF, Muchtar E, Kenderian SS ...

2. A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3) - Mayo Clinic

   This is a single arm, open-label, multi-center, phase 1/2 study, to determine the safety and efficacy of KTE-X19, an autologous anti-CD19 chimeric antigen ...

3. The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation - Mayo Clinic

   About this study. The purpose of this study is to compare the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation (DOAC) use versus ...

4. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

   The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in patients ...

5. Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

6. Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) - Mayo Clinic

   Atrial fibrillation increases the chance of having a heart attack or stroke. Some patients also get new heart valves using a catheter. Often doctors give ...

7. Study to Evaluate Chemoembolization Combined with Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma - Mayo Clinic

   The purpose of this global study is to evaluate transarterial chemoembolization (TACE) in combination with durvalumab and bevacizumab therapy in patients with ...

8. Regorafenib in Metastatic Colorectal Cancer - Mayo Clinic

   About this study. The purpose of the study is to measure high grade (3-5) toxicity of regorafenib and to monitor the impact of treatment with regorafenib on ...

9. Patient Stories - Aniket A. Saoji, Ph.D. - Mayo Clinic

   Mayo Clinic and our partners use technologies such as cookies to collect information from your browser to deliver relevant advertising on our site, in emails ...

10. Abhishek A. Mangaonkar, M.B.B.S. - Mayo Clinic Faculty Profiles

    Abhishek A. Mangaonkar, M.B.B.S., studies the immune microenvironment of myeloid cancers and bone marrow failure syndromes.